Triazaspiro compounds useful for treating or preventing pain

Details Triazaspiro compounds useful for treating or preventing pain Triazaspiro compounds useful for treating or preventing pain

2005-06-16

2008-08-19

Desai, Rita (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S018000

Reexamination Certificate

active

07414062

ABSTRACT:
Triazaspiro Compounds, compositions comprising a Triazaspiro Compound, methods for treating or preventing pain in an animal comprising administering to an animal in need thereof an effective amount of a Triazaspiro Compound and methods for stimulating opioid-receptor function in a cell comprising contacting a cell capable of expressing an opioid receptor with an effective amount of a Triazaspiro Compound are disclosed.

REFERENCES:
patent: 3155669 (1964-11-01), Janssen et al.
patent: 3161644 (1964-12-01), Janssen et al.
patent: 3238216 (1966-03-01), Janssen et al.
patent: 3536809 (1970-10-01), Applezweig et al.
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4374245 (1983-02-01), Davis et al.
patent: 4409230 (1983-10-01), Davis et al.
patent: 4418067 (1983-11-01), Davis et al.
patent: 5059595 (1991-10-01), Le Grazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5698155 (1997-12-01), Grosswald et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5739336 (1998-04-01), Weinhardt et al.
patent: 5789402 (1998-08-01), Audia et al.
patent: 5807865 (1998-09-01), Harrison et al.
patent: 5852029 (1998-12-01), Fisher
patent: 6060482 (2000-05-01), Heine et al.
patent: 6277991 (2001-08-01), Hohlweg et al.
patent: 6362203 (2002-03-01), Mogi et al.
patent: 6686370 (2004-02-01), Kyle et al.
patent: 0 921 125 (1998-06-01), None
patent: 0 856 514 (1998-08-01), None
patent: WO 99/45011 (1999-09-01), None
patent: WO 99/59997 (1999-11-01), None
patent: WO 9959997 (1999-11-01), None
patent: WO 00/06545 (2000-02-01), None
patent: WO 0006545 (2000-02-01), None
patent: WO 01/07050 (2001-02-01), None
patent: WO 01/36418 (2001-05-01), None
patent: WO 01/39723 (2001-06-01), None
Caplus English Abstract DN 65:47734 (US 3238216) 1966.
Caplus English Abstract DN 62:43943 (US 3155670) 1964.
Caplus English Abstract DN 60:90893 (US 633914) 1963.
Gorissen et al.. Differentiation of solubilized dopamine receptors from spirodecanone binding sites in rat striatum. FEBS Lett. Nov. 17, 1980;121(1):133-8.
Saucin et al., Caplus English Abstract DN 78:3415, 1972.
Jansen C., Caplus English Abstract DN 60:90893 BE 633914, 1963.
Wittenberg et al., J. Org. Chem. 1993, 58:4139-4141.
Grupp et al. Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts. J Mol Cell Cardiol. Jan. 1999;31(1):297-303.

Affiliated with

Also associated with

Rating

Triazaspiro compounds useful for treating or preventing pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazaspiro compounds useful for treating or preventing pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazaspiro compounds useful for treating or preventing pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4017318